Nootropic

Nootropics ( , or ) (colloquial: smart drugs and cognitive enhancers, similar to adaptogens) are a wide range of natural or synthetic supplements or drugs and other substances that are claimed to improve cognitive function or to promote relaxation, particularly boosting mood, executive functions, attention, memory, creativity, or motivation in healthy individuals.

The use of cognition-enhancing supplements by healthy individuals in the absence of a medical indication spans numerous controversial issues, including the ethics and fairness of their use, concerns over adverse effects, and the diversion of prescription drugs for non-medical uses. Nonetheless, the international sales of cognitive- or mood-enhancing supplements have continued to grow over time and in 2012 reached 0.69 billion. With sales supported by global health trends, the market is expected to reach US$33.85 billion by the year 2030, at a CAGR of 14.8%.

While most nootropics are not regulated, there are other nootropics like theanine, which the Food and Drug Administration (FDA) considers to be generally recognized as safe (GRAS) and allows its sale as a dietary supplement.

They are often found in supplement form as nutraceuticals, or in recent years, as functional food or drinks. Recently, some companies even began using nootropics in beer as an alcohol replacement.

History and definition

The term ''nootropic'' is derived . It was first introduced by Corneliu Giurgea in 1972 to describe a new classification of molecules that acted selectively towards the brain's higher-level integrative activity. In order for a product to qualify as a true nootropic, it must fulfill Giurgea's five criteria for the category.

# It should aid with improvement in working memory and learning.
# Supports brain function under hypoxic conditions or after electroconvulsive therapy.
# Protection of the brain from physical or chemical toxicity.
# Natural cognitive functions are enhanced.
# It requires to be non-toxic to humans, without depression or stimulation of the brain.

Marketing claims

Nootropics are often advertised with unproven claims of effectiveness at improving cognition. The FDA and FTC warned manufacturers and consumers in 2019 about possible advertising fraud and marketing scams concerning nootropic supplement products. The FDA and FTC stated that some nootropic products had not been approved as a drug effective for any medical purpose, were not proven to be safe, and were illegally marketed in the United States under violation of the Federal Food, Drug, and Cosmetic Act.

Having said that, there are some nootropics like Theanine, that the Food and Drug Administration (FDA) considered generally recognized as safe (GRAS) and allows its sale as a dietary supplement.

In 2018 in the United States, some nootropic supplements were identified as having misleading ingredients and illegal marketing. In 2019, the US Food and Drug Administration (FDA) and Federal Trade Commission (FTC) warned manufacturers and consumers about possible advertising fraud and marketing scams concerning nootropic supplements.

Over the years 2010 to 2019, the FDA warned numerous supplement manufacturers about the illegal status of their products as unapproved drugs with no proven safety or efficacy at the doses recommended, together with misleading marketing.

Availability and prevalence

In 2008, the most commonly used class of drug was stimulants, such as caffeine. Manufacturers' marketing claims for dietary supplements are usually not formally tested and verified by independent entities.

In 2016, the American Medical Association adopted a policy to discourage prescriptions of nootropics for healthy people, on the basis that the cognitive effects appear to be highly variable among individuals, are dose-dependent, and limited or modest at best.

Use by students

The use of prescription stimulants is especially prevalent among students. Surveys suggest that 0.7–4.5% of German students have used cognitive enhancers in their lifetimes. Stimulants such as dimethylamylamine and methylphenidate are used on college campuses and by younger groups. Based upon studies of self-reported illicit stimulant use, of college students use diverted ADHD stimulants, which are primarily used for enhancement of academic performance rather than as recreational drugs. Several factors positively and negatively influence an individual's willingness to use a drug for the purpose of enhancing cognitive performance. Among them are personal characteristics, drug characteristics, and characteristics of the social context.

Side effects

The main concern with pharmaceutical drugs is adverse effects, which also apply to nootropics with undefined effect. Long-term safety evidence is typically unavailable for nootropics. Racetams, piracetam and other compounds that are structurally related to piracetam, have few serious adverse effects and low toxicity, but there is little evidence that they enhance cognition in people having no cognitive impairments.

In the United States, dietary supplements may be marketed if the manufacturer can show that the supplement is generally recognized as safe, and if the manufacturer does not make any claims about using the supplement to treat or prevent any disease or condition; supplements that contain drugs or advertise health claims are illegal under US law.

Types

Central nervous system stimulants

Systematic reviews and meta-analyses of clinical human research using low doses of certain central nervous system stimulants found that these drugs enhance cognition in healthy people. In particular, the classes of stimulants that demonstrate cognition-enhancing effects in humans act as direct agonists or indirect agonists of dopamine receptor D₁, adrenoceptor A₂, or both types of receptor in the prefrontal cortex. Relatively high doses of stimulants cause cognitive deficits.

* Amphetamine systematic reviews and meta-analyses report that low-dose amphetamine improves cognitive functions (e.g., inhibitory control, episodic memory, working memory, and aspects of attention) in healthy people and in individuals with ADHD. A 2014 systematic review noted that low doses of amphetamine also improve memory consolidation, in turn leading to improved recall of information in non-ADHD youth. It also improves task saliency (motivation to perform a task) and performance on tedious tasks that required a high degree of effort.
* Methylphenidate a benzylpiperidine derivative that improves working memory, episodic memory, and inhibitory control, aspects of attention, and planning latency in healthy people. It also may improve task saliency and performance on tedious tasks. At above optimal doses, methylphenidate has off–target effects that decrease learning.
* Eugeroics ( armodafinil and modafinil) are classified as "wakefulness-promoting agents"; modafinil increases alertness, particularly in sleep-deprived individuals, and facilitates reasoning and problem solving in non-ADHD youth. In a systematic review of small, preliminary studies where the effects of modafinil were examined, when simple psychometric assessments were considered, modafinil intake enhanced executive function. Modafinil may not produce improvements in mood or motivation in sleep deprived or non-sleep deprived individuals.
* Caffeine a meta-analysis found an increase in alertness and attentional performance.
* Nicotine a meta-analysis of 41 clinical studies concluded that nicotine administration or smoking improves alerting and orienting attention and episodic and working memory and slightly improves fine motor performance.

Amino acids

A 2016 review reported that theanine may increase alpha waves in the brain. Alpha waves may contribute to a relaxed yet alert mental state. Another study has shown that an oral administration of theanine at doses of 50–200 mg promoted "relaxation without causing drowsiness" within 40 mins after consumption. A 2014 systematic review and meta-analysis found that concurrent caffeine and -theanine use had synergistic psychoactive effects that promoted alertness, attention, and task switching. These effects were most pronounced during the first hour post-dose.

* Theaninea study found that in healthy human subjects, ''α''-waves were generated on the occipital and parietal regions of the brain surface within 40 min after the oral administration of theanine (50–200 mg), signifying relaxation without causing drowsiness.

Racetams

Racetams, such as piracetam, oxiracetam, phenylpiracetam, and aniracetam, are often marketed as cognitive enhancers and sold over the counter. A 2019 study found that piracetam supplements sold in the United States were inaccurately labeled. Racetams are often referred to as nootropics, but this property is not well established. The racetams have poorly understood mechanisms, although piracetam and aniracetam are known to act as positive allosteric modulators of AMPA receptors and appear to modulate cholinergic systems.

According to the US Food and Drug Administration,

Piracetam is not a vitamin, mineral, amino acid, herb or other botanical, or dietary substance for use by humans to supplement the diet by increasing the total dietary intake. Further, piracetam is not a concentrate, metabolite, constituent, extract or combination of any such dietary ingredient. ..Accordingly, these products are drugs, under section 201(g)(1)(C) of the Act, 21 U.S.C. § 321(g)(1)(C), because they are not foods and they are intended to affect the structure or any function of the body. Moreover, these products are new drugs as defined by section 201(p) of the Act, 21 U.S.C. § 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling.

Cholinergics

Some of the most widely used nootropic substances are the cholinergics. These are typically compounds and analogues of choline. Choline is an essential nutrient needed for the synthesis of acetylcholine (a neurotransmitter), and phosphatidylcholine (a structural component of brain cell membranes).
* Citicoline - Compound consisting of choline and cytidine. Several meta-analyses found that it is likely effective for improving memory and learning in older people with mild cognitive decline, as well as in people who are recovering from a stroke. There is little evidence it enhances cognition in young, healthy people.
* Choline bitartrate - Choline bitartrate is a tartaric acid salt containing choline (41% choline by molecular weight). At least one meta-analysis has found choline bitartrate to be ineffective at improving any measure of cognitive performance.
* Alpha-GPC - L-Alpha glycerylphosphorylcholine has thus far only been studied in the context of cognitive performance alongside other substances such as caffeine. A more comprehensive meta-analysis is needed before any strong conclusions are made about Alpha-GPC's usefulness as a nootropic.

Miscellaneous

* Tolcapone a systematic review noted that it improved verbal episodic memory and episodic memory encoding.
* Levodopa a systematic review noted that it improved verbal episodic memory and episodic memory encoding.
* Atomoxetine may improve working memory and attention when used at certain doses.
* Desipramine may improve working memory and attention when used at certain doses.
* Nicergoline may improve human cognitive performance, including concentration, psychomotor performance, attention, reaction times, and other indicators of brain function.
* ISRIB enhanced spatial and fear-associated learning.

The cognitive enhancing effects of pramipexole, guanfacine, clonidine, and fexofenadine have been tested, but no significant cognition-enhancing effects in healthy individuals were found.

Psychedelic microdosing is the novel practice of using sub-threshold doses (microdoses) of psychedelic drugs in an attempt to improve mood and cognition. The efficacy of this has not been verified. In a study examining the qualitative reports of 278 microdosers the researchers found that there were mixed results among users. While some users reported positive effects such as improved mood and cognition, others paradoxically reported negative effects such as physiological discomfort and anxiety. In one of the only double-blind, randomized studies to date, those given microdoses of LSD did not perform better than those given the placebo on cognitive tasks.

Herbs

*''Bacopa monnieri'' is used in Ayurvedic traditional medicine to improve cognition. In 2019, the US Food and Drug Administration (FDA) warned manufacturers of dietary supplement products containing ''Bacopa monnieri'' against making illegal and unproven claims that the herb can treat various diseases.
* ''Panax ginseng'' A review by the Cochrane Collaboration found that the results of its analysis "suggested improvement of some aspects of cognitive function, behavior and quality of life" but concluded that "there is a lack of convincing evidence to show a cognitive enhancing effect of ''Panax ginseng'' in healthy participants and no high quality evidence about its efficacy in patients with dementia."
* ''Ginkgo biloba'' An extract of ''Ginkgo biloba'' leaf is marketed in dietary supplement form with claims it can enhance cognitive function in people without known cognitive problems, although there is no high-quality evidence to support such effects on memory or attention in healthy people.
* ''Salvia officinalis and lavandulaefolia'' (sage) Some research has suggested certain extracts of ''Salvia officinalis'' may have positive effects on human brain function, but due to significant methodological problems, no firm conclusions can be drawn. The thujone present in ''Salvia'' extracts may be neurotoxic.
* ''Centella asiatica'' A 2017 meta-analysis with 11 studies (5 RCTs with placebo, 6 using other herbs as a comparison group) showing no significant improvement in all cognitive function, however may have some use in improving mood and anger. Overall dosages were smaller than the typical 3 grams used traditionally.

Nutrients and dietary supplements

A 2015 review found that use of omega-3 fatty acids, B vitamins, and vitamin E as nootropics was ineffective on cognitive function in normal middle-aged and older people.

* Omega-3 fatty acids: DHA and EPA two Cochrane Collaboration reviews on the use of supplemental omega-3 fatty acids for ADHD and learning disorders conclude that there is limited evidence of treatment benefits for either disorder. Two other systematic reviews found no cognition-enhancing effects in the general population.
* Folate no cognition-enhancing effects in middle-aged and older adults without folate deficiency.
* Vitamin B₆ no cognition-enhancing effects in middle-aged and older adults without B6 deficiency.
* Vitamin B₁₂ no cognition-enhancing effects in middle-aged and older adults without B12 deficiency.
* Vitamin E no cognition-enhancing effects in middle-aged and older adults without vitamin E deficiency.

See also

* Cognitive science
* Evidence-based learning
* ''Flowers for Algernon'', a novel on the subject of enhancing intelligence
* Human enhancement
* List of drugs used by militaries
* Neuroenhancement
* Neuropharmacology
* Neuroplastic effects of pollution
* Neuropsychopharmacology
* Nutritional neuroscience
*
* Psychoactive drug
*

References

External links

*

{{Authority control

1970s neologisms
Amphetamine
Methylphenidate